#United States #Plymouth Meeting #NCCN #Cancer Care #Policy Summit

NCCN Policy Summit Webinar on Innovations in Cancer Care

The National Comprehensive Cancer Network® (NCCN®) is gearing up for an insightful online event – the NCCN Policy Summit Webinar. Scheduled for Thursday, June 25, 2026, from 1:00 PM to 3:30 PM EDT, this summit aims to gather diverse perspectives from patients, advocates, providers, payers, and policymakers. The discussion will center around how key innovations in cancer therapies and treatment modalities have shaped the current landscape of oncology care.

Webinar Highlights

During the webinar, attendees will delve into:

• - The successes of collaborative and supportive research environments that have propelled advancements in cancer treatment.
• - Areas promising future innovations that can further enhance cancer care.
• - The current financial structure of the clinical research ecosystem and its implications for ongoing advancements in patient care.

Participants will also discuss the prevailing challenges faced in maintaining an innovative environment in the field of oncology and the opportunities available to overcome these hurdles. Such discussions are vital as they can lead to improved outcomes for future generations affected by cancer.

Notable Speakers

The event will feature prestigious speakers including:

• - Diana DeGette, JD (CO-01) - Congresswoman, who will deliver remarks highlighting policy impacts on cancer care.
• - Christopher Lieu, MD - Co-Director of Gastrointestinal Medical Oncology at the University of Colorado Cancer Center and Vice-Chair of the NCCN Board of Directors, who will provide a keynote address based on his extensive experience in oncology.
• - Robert Dilley, MD, PhD - A Clinical Fellow at Dana-Farber Cancer Institute, who will share personal patient stories that highlight the real-world implications of cancer treatment advancements.
• - Randy Burkholder - Current Vice President of Policy and Research at PhRMA, who will shed light on the pharmaceutical industry’s role in shaping cancer care policy.
• - James H. Doroshow, MD - Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, who will offer a scientific perspective on emerging therapies.

Additional Context

The NCCN, a not-for-profit alliance of leading cancer centers, is dedicated to enhancing the quality, effectiveness, and accessibility of cancer care. Their Clinical Practice Guidelines in Oncology are recognized as a standard of care, offering evidence-based recommendations that empower healthcare providers and patients alike. The guidelines serve as a cornerstone for clinical direction in cancer management.

This summit is not only an opportunity to hear from experts but also fosters discussions that can lead to tangible changes in policy and practice in oncology. For those interested in attending, registration details and further information can be found on the NCCN website.

As interest in innovations in cancer care grows, events like the NCCN Policy Summit Webinar play a crucial role in connecting various stakeholders, sharing insights, and driving progress in the fight against cancer. Whether you're a patient, a healthcare provider, an advocate, or a researcher, your involvement is vital for shaping the future of cancer care. Join the discussion and contribute to this important field's progress during the webinar.

Contact for Media Representation

Members of the media can reach out to Rachel Darwin at [email protected] for complimentary registration to the event, ensuring that the important conversations happening at the summit are shared widely to inform and engage communities around the continuous developments in cancer care.

Overall, the NCCN Policy Summit Webinar promises an engaging experience centered on critical discussions about the future of cancer therapies and the policies that will ensure their advancement. Don't miss this chance to be a part of a transformative conversation that aims to influence the landscape of cancer treatment for years to come.